chr1-111982044-CAGA-C
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM2PM4_SupportingPP5_Very_Strong
The NM_001378969.1(KCND3):c.680_682delTCT(p.Phe227del) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. F227F) has been classified as Likely benign.
Frequency
Consequence
NM_001378969.1 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Publications
- neurodevelopmental disorderInheritance: AD Classification: STRONG Submitted by: G2P
- spinocerebellar ataxia type 19/22Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, Ambry Genetics
- Brugada syndrome 9Inheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp
- Brugada syndrome 1Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KCND3 | NM_001378969.1 | c.680_682delTCT | p.Phe227del | disruptive_inframe_deletion | Exon 2 of 8 | ENST00000302127.5 | NP_001365898.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Spinocerebellar ataxia type 19/22 Pathogenic:3
- -
Variant summary: KCND3 c.680_682delTCT (p.Phe227del) results in an in-frame deletion that is predicted to remove one amino acid from the Ion transport domain (IPR005821) of the encoded protein. The variant was absent in 250304 control chromosomes. c.680_682delTCT has been reported in the literature to cosegregate with disease in multiple individuals from two independent well genotyped families affected with Spinocerebellar Ataxia Type 22, which overlaps with the locus of Spinocerebellar Ataxia Type 19 (example, Lee_2012). It has also been reported among pathogenic variants identified in at-least one individual within a cohort of individuals undergoing next-generation sequencing (NGS) analysis for Herediatry Ataxia's (example, Galatolo_2021). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function (Lee_2012). The most pronounced variant effect results in low current densities by electrophysiological recordings and intracellular retention, suggesting that p.F227del causes a loss of channel function by interfering with proper plasma membrane targeting and incorporation into a functional tetrameric channel complex. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
not provided Pathogenic:2
This variant has been identified in multiple unrelated individuals with clinical features associated with this gene. This variant has not been reported in large, multi-ethnic general populations. (http://gnomad.broadinstitute.org) This variant segregates with disease in multiple families. Assessment of experimental evidence suggests this variant results in abnormal protein function. (PMID: 23280837, 25854634) -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at